Th17 cells, which are a subset of effector CD4+ T cells specialized in the production of IL-17 and IL-22 and in recruitment and activation of neutrophils, have been implicated in autoimmune diseases, including multiple sclerosis, lupus and diabetes [57]. Here, IL22 is linked to diabetes mellitus.